Cargando…
Integrin β5 is an independent prognostic marker for intrahepatic cholangiocarcinoma in a Chinese population
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver tumor and a major cause of cancer mortality worldwide. Integrin β5 (ITGB5) is considered to be involved in the intercellular signal transduction and regulation of tumorigenesis and development. The present study investigat...
Autores principales: | Ma, Lixing, Song, Kang, Zang, Jinfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587877/ https://www.ncbi.nlm.nih.gov/pubmed/37869645 http://dx.doi.org/10.3892/etm.2023.12231 |
Ejemplares similares
-
Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma
por: Yang, Sheng-Huei, et al.
Publicado: (2015) -
β4 and β6 Integrin Expression Is Associated with the Subclassification and Clinicopathological Features of Intrahepatic Cholangiocarcinoma
por: Soejima, Yurie, et al.
Publicado: (2018) -
Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013) -
iNOS is associated with tumorigenicity as an independent prognosticator in human intrahepatic cholangiocarcinoma
por: Liu, Sulai, et al.
Publicado: (2019) -
CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma
por: Huang, Gong -Kai, et al.
Publicado: (2017)